Angiogenesis 2024: The implication of longitudinal AI-based fluid quantification for at-home monitoring

Anat Loewenstein, MD, sat down with Hattie Hayes of Ophthalmology Times Europe to discuss the implication of longitudinal AI-based fluid quantification for at-home monitoring from the Angiogenesis Exudation and Degeneration 2024 event.

Related Videos

Related Content

Advertisement

January 23rd 2025

1-year results from HELIOS trial show stability or improvement in treating NPDR

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

January 22nd 2025

Study reveals temperature fluctuations at home may compromise anti-VEGF drug safety

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

January 13th 2025

Formycon partners with Teva, Klinge Biopharma for commercialization of aflibercept biosimilar FYB203 (AHZANTIVE)

January 11th 2025

New research links retinal imaging and deep learning to improved schizophrenia detection

Related Content

Advertisement

January 23rd 2025

1-year results from HELIOS trial show stability or improvement in treating NPDR

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

January 22nd 2025

Study reveals temperature fluctuations at home may compromise anti-VEGF drug safety

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

January 13th 2025

Formycon partners with Teva, Klinge Biopharma for commercialization of aflibercept biosimilar FYB203 (AHZANTIVE)

January 11th 2025

New research links retinal imaging and deep learning to improved schizophrenia detection